Cardiff Oncology

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.

About CRDF

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. 

CEO
Mark Erlander
CEOMark Erlander
Employees
23
Employees23
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
23
Employees23

CRDF Key Statistics

Market cap
66.30M
Market cap66.30M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
666.24K
Average volume666.24K
High today
$1.63
High today$1.63
Low today
$1.52
Low today$1.52
Open price
$1.56
Open price$1.56
Volume
439.78K
Volume439.78K
52 Week high
$7.32
52 Week high$7.32
52 Week low
$1.13
52 Week low$1.13

CRDF Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.